Results
1 -
10 of
47
(Click
here to explore results)
- CDK9 inhibitors in cancer research. Zhi Huang, Tianqi Wang, Cheng Wang, Yan Fan
, RSC Med. Chem.
, 2022
, 13
, 688
- A self-amplifying nanodrug to manipulate the Janus-faced nature of ferroptosis for tumor therapy. Mengzhu Zhang, Xiaohan Qin, Zhipeng Zhao, Qian Du, Qian Li, Yue Jiang, Yuxia Luan
, Nanoscale Horiz.
, 2022
, 7
, 198
- Synthesis of 6,8-diaminopurines via acid-induced cascade cyclization of 5-aminoimidazole precursors and preliminary anticancer evaluation. Nádia R. Senhorães, Bruna F. Silva, Raquel Sousa, Bruna P. Leite, Jorge M. Gonçalves, Filipe A. Almeida Paz, Cristina Pereira-Wilson, Alice M. Dias
, Org. Biomol. Chem.
, 2024
, 22
, 1500
- Discovery of pyrazolo[3,4-d]pyrimidine and pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives as novel CDK2 inhibitors: synthesis, biological and molecular modeling investigations. Ibrahim F. Nassar, Mohammed T. Abdel Aal, Wael A. El-Sayed, Mahmoud A. E Shahin, Elsayed G. E. Elsakka, Mahmoud Mohamed Mokhtar, Maghawry Hegazy, Mohamed Hagras, Asmaa A. Mandour, Nasser S. M. Ismail
, RSC Adv.
, 2022
, 12
, 14865
- Natural products as kinase inhibitors. Jing Liu, Yi Hu, David L. Waller, Junfeng Wang, Qingsong Liu
, Nat. Prod. Rep.
, 2012
, 29
, 392
- Discrimination of normal and malignant mouse ovarian surface epithelial cells in vitro using Raman microspectroscopy. S. Borel, E. A. Prikryl, N. H. Vuong, J. Jonkman, B. Vanderhyden, B. C. Wilson, S. Murugkar
, Anal. Methods
, 2015
, 7
, 9520
- Pyrrolizine/indolizine-bearing (un)substituted isoindole moiety: design, synthesis, antiproliferative and MDR reversal activities, and in silico studies . Amr L. AbdelSamad, Mohammed T. El-Saadi, Ahmed M. Gouda, Asmaa M. AboulMagd
, RSC Adv.
, 2023
, 13
, 30753
- Transformations of the natural cytokinin N6-isopentenyladenine in aqueous acidic media: structural aspects. Zdeněk Trávníček, Radka Novotná, Jaromír Marek, Igor Popa, Michal Šipl
, Org. Biomol. Chem.
, 2011
, 9
, 5703
- Insights into the medicinal chemistry of heterocycles integrated with a pyrazolo[1,5-a]pyrimidine scaffold. Mohamed M. Hammouda, Hatem E. Gaffer, Khaled M. Elattar
, RSC Med. Chem.
, 2022
, 13
, 1150
- Drug repositioning through incomplete bi-cliques in an integrated drug–target–disease network. Simone Daminelli, V. Joachim Haupt, Matthias Reimann, Michael Schroeder
, Integr. Biol.
, 2012
, 4
, 778